Global Newborn Screening for SMA and SCID Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Newborn Screening for SMA and SCID market size was valued at US$ 126.4 million in 2023. With growing demand in downstream market, the Newborn Screening for SMA and SCID is forecast to a readjusted size of US$ 278.4 million by 2030 with a CAGR of 11.9% during review period.
The research report highlights the growth potential of the global Newborn Screening for SMA and SCID market. Newborn Screening for SMA and SCID are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Newborn Screening for SMA and SCID. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Newborn Screening for SMA and SCID market.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
Key Features:
The report on Newborn Screening for SMA and SCID market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Newborn Screening for SMA and SCID market. It may include historical data, market segmentation by Type (e.g., Instruments, Kits), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Newborn Screening for SMA and SCID market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Newborn Screening for SMA and SCID market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Newborn Screening for SMA and SCID industry. This include advancements in Newborn Screening for SMA and SCID technology, Newborn Screening for SMA and SCID new entrants, Newborn Screening for SMA and SCID new investment, and other innovations that are shaping the future of Newborn Screening for SMA and SCID.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Newborn Screening for SMA and SCID market. It includes factors influencing customer ' purchasing decisions, preferences for Newborn Screening for SMA and SCID product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Newborn Screening for SMA and SCID market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Newborn Screening for SMA and SCID market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Newborn Screening for SMA and SCID market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Newborn Screening for SMA and SCID industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Newborn Screening for SMA and SCID market.
Market Segmentation:
Newborn Screening for SMA and SCID market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Newborn Screening for SMA and SCID market size was valued at US$ 126.4 million in 2023. With growing demand in downstream market, the Newborn Screening for SMA and SCID is forecast to a readjusted size of US$ 278.4 million by 2030 with a CAGR of 11.9% during review period.
The research report highlights the growth potential of the global Newborn Screening for SMA and SCID market. Newborn Screening for SMA and SCID are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Newborn Screening for SMA and SCID. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Newborn Screening for SMA and SCID market.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
Key Features:
The report on Newborn Screening for SMA and SCID market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Newborn Screening for SMA and SCID market. It may include historical data, market segmentation by Type (e.g., Instruments, Kits), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Newborn Screening for SMA and SCID market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Newborn Screening for SMA and SCID market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Newborn Screening for SMA and SCID industry. This include advancements in Newborn Screening for SMA and SCID technology, Newborn Screening for SMA and SCID new entrants, Newborn Screening for SMA and SCID new investment, and other innovations that are shaping the future of Newborn Screening for SMA and SCID.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Newborn Screening for SMA and SCID market. It includes factors influencing customer ' purchasing decisions, preferences for Newborn Screening for SMA and SCID product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Newborn Screening for SMA and SCID market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Newborn Screening for SMA and SCID market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Newborn Screening for SMA and SCID market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Newborn Screening for SMA and SCID industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Newborn Screening for SMA and SCID market.
Market Segmentation:
Newborn Screening for SMA and SCID market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Instruments
- Kits
- Software
- SCID Screening
- SMA Screening
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Perkinelmer
- Thermo Fisher
- ImmunoIVD
- Labsystems Diagnostics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Newborn Screening for SMA and SCID Market Size 2019-2030
2.1.2 Newborn Screening for SMA and SCID Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Newborn Screening for SMA and SCID Segment by Type
2.2.1 Instruments
2.2.2 Kits
2.2.3 Software
2.3 Newborn Screening for SMA and SCID Market Size by Type
2.3.1 Newborn Screening for SMA and SCID Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
2.4 Newborn Screening for SMA and SCID Segment by Application
2.4.1 SCID Screening
2.4.2 SMA Screening
2.5 Newborn Screening for SMA and SCID Market Size by Application
2.5.1 Newborn Screening for SMA and SCID Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
3 NEWBORN SCREENING FOR SMA AND SCID MARKET SIZE BY PLAYER
3.1 Newborn Screening for SMA and SCID Market Size Market Share by Players
3.1.1 Global Newborn Screening for SMA and SCID Revenue by Players (2019-2024)
3.1.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Players (2019-2024)
3.2 Global Newborn Screening for SMA and SCID Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEWBORN SCREENING FOR SMA AND SCID BY REGIONS
4.1 Newborn Screening for SMA and SCID Market Size by Regions (2019-2024)
4.2 Americas Newborn Screening for SMA and SCID Market Size Growth (2019-2024)
4.3 APAC Newborn Screening for SMA and SCID Market Size Growth (2019-2024)
4.4 Europe Newborn Screening for SMA and SCID Market Size Growth (2019-2024)
4.5 Middle East & Africa Newborn Screening for SMA and SCID Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Newborn Screening for SMA and SCID Market Size by Country (2019-2024)
5.2 Americas Newborn Screening for SMA and SCID Market Size by Type (2019-2024)
5.3 Americas Newborn Screening for SMA and SCID Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Newborn Screening for SMA and SCID Market Size by Region (2019-2024)
6.2 APAC Newborn Screening for SMA and SCID Market Size by Type (2019-2024)
6.3 APAC Newborn Screening for SMA and SCID Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Newborn Screening for SMA and SCID by Country (2019-2024)
7.2 Europe Newborn Screening for SMA and SCID Market Size by Type (2019-2024)
7.3 Europe Newborn Screening for SMA and SCID Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Newborn Screening for SMA and SCID by Region (2019-2024)
8.2 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Type (2019-2024)
8.3 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEWBORN SCREENING FOR SMA AND SCID MARKET FORECAST
10.1 Global Newborn Screening for SMA and SCID Forecast by Regions (2025-2030)
10.1.1 Global Newborn Screening for SMA and SCID Forecast by Regions (2025-2030)
10.1.2 Americas Newborn Screening for SMA and SCID Forecast
10.1.3 APAC Newborn Screening for SMA and SCID Forecast
10.1.4 Europe Newborn Screening for SMA and SCID Forecast
10.1.5 Middle East & Africa Newborn Screening for SMA and SCID Forecast
10.2 Americas Newborn Screening for SMA and SCID Forecast by Country (2025-2030)
10.2.1 United States Newborn Screening for SMA and SCID Market Forecast
10.2.2 Canada Newborn Screening for SMA and SCID Market Forecast
10.2.3 Mexico Newborn Screening for SMA and SCID Market Forecast
10.2.4 Brazil Newborn Screening for SMA and SCID Market Forecast
10.3 APAC Newborn Screening for SMA and SCID Forecast by Region (2025-2030)
10.3.1 China Newborn Screening for SMA and SCID Market Forecast
10.3.2 Japan Newborn Screening for SMA and SCID Market Forecast
10.3.3 Korea Newborn Screening for SMA and SCID Market Forecast
10.3.4 Southeast Asia Newborn Screening for SMA and SCID Market Forecast
10.3.5 India Newborn Screening for SMA and SCID Market Forecast
10.3.6 Australia Newborn Screening for SMA and SCID Market Forecast
10.4 Europe Newborn Screening for SMA and SCID Forecast by Country (2025-2030)
10.4.1 Germany Newborn Screening for SMA and SCID Market Forecast
10.4.2 France Newborn Screening for SMA and SCID Market Forecast
10.4.3 UK Newborn Screening for SMA and SCID Market Forecast
10.4.4 Italy Newborn Screening for SMA and SCID Market Forecast
10.4.5 Russia Newborn Screening for SMA and SCID Market Forecast
10.5 Middle East & Africa Newborn Screening for SMA and SCID Forecast by Region (2025-2030)
10.5.1 Egypt Newborn Screening for SMA and SCID Market Forecast
10.5.2 South Africa Newborn Screening for SMA and SCID Market Forecast
10.5.3 Israel Newborn Screening for SMA and SCID Market Forecast
10.5.4 Turkey Newborn Screening for SMA and SCID Market Forecast
10.5.5 GCC Countries Newborn Screening for SMA and SCID Market Forecast
10.6 Global Newborn Screening for SMA and SCID Forecast by Type (2025-2030)
10.7 Global Newborn Screening for SMA and SCID Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Perkinelmer
11.1.1 Perkinelmer Company Information
11.1.2 Perkinelmer Newborn Screening for SMA and SCID Product Offered
11.1.3 Perkinelmer Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Perkinelmer Main Business Overview
11.1.5 Perkinelmer Latest Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Information
11.2.2 Thermo Fisher Newborn Screening for SMA and SCID Product Offered
11.2.3 Thermo Fisher Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Main Business Overview
11.2.5 Thermo Fisher Latest Developments
11.3 ImmunoIVD
11.3.1 ImmunoIVD Company Information
11.3.2 ImmunoIVD Newborn Screening for SMA and SCID Product Offered
11.3.3 ImmunoIVD Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 ImmunoIVD Main Business Overview
11.3.5 ImmunoIVD Latest Developments
11.4 Labsystems Diagnostics
11.4.1 Labsystems Diagnostics Company Information
11.4.2 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Offered
11.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Labsystems Diagnostics Main Business Overview
11.4.5 Labsystems Diagnostics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Newborn Screening for SMA and SCID Market Size 2019-2030
2.1.2 Newborn Screening for SMA and SCID Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Newborn Screening for SMA and SCID Segment by Type
2.2.1 Instruments
2.2.2 Kits
2.2.3 Software
2.3 Newborn Screening for SMA and SCID Market Size by Type
2.3.1 Newborn Screening for SMA and SCID Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
2.4 Newborn Screening for SMA and SCID Segment by Application
2.4.1 SCID Screening
2.4.2 SMA Screening
2.5 Newborn Screening for SMA and SCID Market Size by Application
2.5.1 Newborn Screening for SMA and SCID Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
3 NEWBORN SCREENING FOR SMA AND SCID MARKET SIZE BY PLAYER
3.1 Newborn Screening for SMA and SCID Market Size Market Share by Players
3.1.1 Global Newborn Screening for SMA and SCID Revenue by Players (2019-2024)
3.1.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Players (2019-2024)
3.2 Global Newborn Screening for SMA and SCID Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEWBORN SCREENING FOR SMA AND SCID BY REGIONS
4.1 Newborn Screening for SMA and SCID Market Size by Regions (2019-2024)
4.2 Americas Newborn Screening for SMA and SCID Market Size Growth (2019-2024)
4.3 APAC Newborn Screening for SMA and SCID Market Size Growth (2019-2024)
4.4 Europe Newborn Screening for SMA and SCID Market Size Growth (2019-2024)
4.5 Middle East & Africa Newborn Screening for SMA and SCID Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Newborn Screening for SMA and SCID Market Size by Country (2019-2024)
5.2 Americas Newborn Screening for SMA and SCID Market Size by Type (2019-2024)
5.3 Americas Newborn Screening for SMA and SCID Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Newborn Screening for SMA and SCID Market Size by Region (2019-2024)
6.2 APAC Newborn Screening for SMA and SCID Market Size by Type (2019-2024)
6.3 APAC Newborn Screening for SMA and SCID Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Newborn Screening for SMA and SCID by Country (2019-2024)
7.2 Europe Newborn Screening for SMA and SCID Market Size by Type (2019-2024)
7.3 Europe Newborn Screening for SMA and SCID Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Newborn Screening for SMA and SCID by Region (2019-2024)
8.2 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Type (2019-2024)
8.3 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEWBORN SCREENING FOR SMA AND SCID MARKET FORECAST
10.1 Global Newborn Screening for SMA and SCID Forecast by Regions (2025-2030)
10.1.1 Global Newborn Screening for SMA and SCID Forecast by Regions (2025-2030)
10.1.2 Americas Newborn Screening for SMA and SCID Forecast
10.1.3 APAC Newborn Screening for SMA and SCID Forecast
10.1.4 Europe Newborn Screening for SMA and SCID Forecast
10.1.5 Middle East & Africa Newborn Screening for SMA and SCID Forecast
10.2 Americas Newborn Screening for SMA and SCID Forecast by Country (2025-2030)
10.2.1 United States Newborn Screening for SMA and SCID Market Forecast
10.2.2 Canada Newborn Screening for SMA and SCID Market Forecast
10.2.3 Mexico Newborn Screening for SMA and SCID Market Forecast
10.2.4 Brazil Newborn Screening for SMA and SCID Market Forecast
10.3 APAC Newborn Screening for SMA and SCID Forecast by Region (2025-2030)
10.3.1 China Newborn Screening for SMA and SCID Market Forecast
10.3.2 Japan Newborn Screening for SMA and SCID Market Forecast
10.3.3 Korea Newborn Screening for SMA and SCID Market Forecast
10.3.4 Southeast Asia Newborn Screening for SMA and SCID Market Forecast
10.3.5 India Newborn Screening for SMA and SCID Market Forecast
10.3.6 Australia Newborn Screening for SMA and SCID Market Forecast
10.4 Europe Newborn Screening for SMA and SCID Forecast by Country (2025-2030)
10.4.1 Germany Newborn Screening for SMA and SCID Market Forecast
10.4.2 France Newborn Screening for SMA and SCID Market Forecast
10.4.3 UK Newborn Screening for SMA and SCID Market Forecast
10.4.4 Italy Newborn Screening for SMA and SCID Market Forecast
10.4.5 Russia Newborn Screening for SMA and SCID Market Forecast
10.5 Middle East & Africa Newborn Screening for SMA and SCID Forecast by Region (2025-2030)
10.5.1 Egypt Newborn Screening for SMA and SCID Market Forecast
10.5.2 South Africa Newborn Screening for SMA and SCID Market Forecast
10.5.3 Israel Newborn Screening for SMA and SCID Market Forecast
10.5.4 Turkey Newborn Screening for SMA and SCID Market Forecast
10.5.5 GCC Countries Newborn Screening for SMA and SCID Market Forecast
10.6 Global Newborn Screening for SMA and SCID Forecast by Type (2025-2030)
10.7 Global Newborn Screening for SMA and SCID Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Perkinelmer
11.1.1 Perkinelmer Company Information
11.1.2 Perkinelmer Newborn Screening for SMA and SCID Product Offered
11.1.3 Perkinelmer Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Perkinelmer Main Business Overview
11.1.5 Perkinelmer Latest Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Information
11.2.2 Thermo Fisher Newborn Screening for SMA and SCID Product Offered
11.2.3 Thermo Fisher Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Main Business Overview
11.2.5 Thermo Fisher Latest Developments
11.3 ImmunoIVD
11.3.1 ImmunoIVD Company Information
11.3.2 ImmunoIVD Newborn Screening for SMA and SCID Product Offered
11.3.3 ImmunoIVD Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 ImmunoIVD Main Business Overview
11.3.5 ImmunoIVD Latest Developments
11.4 Labsystems Diagnostics
11.4.1 Labsystems Diagnostics Company Information
11.4.2 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Offered
11.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Labsystems Diagnostics Main Business Overview
11.4.5 Labsystems Diagnostics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Newborn Screening for SMA and SCID Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Instruments
Table 3. Major Players of Kits
Table 4. Major Players of Software
Table 5. Newborn Screening for SMA and SCID Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Newborn Screening for SMA and SCID Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Table 8. Newborn Screening for SMA and SCID Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Newborn Screening for SMA and SCID Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Table 11. Global Newborn Screening for SMA and SCID Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Newborn Screening for SMA and SCID Revenue Market Share by Player (2019-2024)
Table 13. Newborn Screening for SMA and SCID Key Players Head office and Products Offered
Table 14. Newborn Screening for SMA and SCID Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Newborn Screening for SMA and SCID Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Newborn Screening for SMA and SCID Market Size Market Share by Regions (2019-2024)
Table 19. Global Newborn Screening for SMA and SCID Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Newborn Screening for SMA and SCID Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Newborn Screening for SMA and SCID Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Newborn Screening for SMA and SCID Market Size Market Share by Country (2019-2024)
Table 23. Americas Newborn Screening for SMA and SCID Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Table 25. Americas Newborn Screening for SMA and SCID Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Table 27. APAC Newborn Screening for SMA and SCID Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Newborn Screening for SMA and SCID Market Size Market Share by Region (2019-2024)
Table 29. APAC Newborn Screening for SMA and SCID Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Table 31. APAC Newborn Screening for SMA and SCID Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Table 33. Europe Newborn Screening for SMA and SCID Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Newborn Screening for SMA and SCID Market Size Market Share by Country (2019-2024)
Table 35. Europe Newborn Screening for SMA and SCID Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Table 37. Europe Newborn Screening for SMA and SCID Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Newborn Screening for SMA and SCID
Table 46. Key Market Challenges & Risks of Newborn Screening for SMA and SCID
Table 47. Key Industry Trends of Newborn Screening for SMA and SCID
Table 48. Global Newborn Screening for SMA and SCID Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Newborn Screening for SMA and SCID Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Newborn Screening for SMA and SCID Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Newborn Screening for SMA and SCID Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Perkinelmer Details, Company Type, Newborn Screening for SMA and SCID Area Served and Its Competitors
Table 53. Perkinelmer Newborn Screening for SMA and SCID Product Offered
Table 54. Perkinelmer Newborn Screening for SMA and SCID Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Perkinelmer Main Business
Table 56. Perkinelmer Latest Developments
Table 57. Thermo Fisher Details, Company Type, Newborn Screening for SMA and SCID Area Served and Its Competitors
Table 58. Thermo Fisher Newborn Screening for SMA and SCID Product Offered
Table 59. Thermo Fisher Main Business
Table 60. Thermo Fisher Newborn Screening for SMA and SCID Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Thermo Fisher Latest Developments
Table 62. ImmunoIVD Details, Company Type, Newborn Screening for SMA and SCID Area Served and Its Competitors
Table 63. ImmunoIVD Newborn Screening for SMA and SCID Product Offered
Table 64. ImmunoIVD Main Business
Table 65. ImmunoIVD Newborn Screening for SMA and SCID Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. ImmunoIVD Latest Developments
Table 67. Labsystems Diagnostics Details, Company Type, Newborn Screening for SMA and SCID Area Served and Its Competitors
Table 68. Labsystems Diagnostics Newborn Screening for SMA and SCID Product Offered
Table 69. Labsystems Diagnostics Main Business
Table 70. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Labsystems Diagnostics Latest Developments
Table 1. Newborn Screening for SMA and SCID Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Instruments
Table 3. Major Players of Kits
Table 4. Major Players of Software
Table 5. Newborn Screening for SMA and SCID Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Newborn Screening for SMA and SCID Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Table 8. Newborn Screening for SMA and SCID Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Newborn Screening for SMA and SCID Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Table 11. Global Newborn Screening for SMA and SCID Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Newborn Screening for SMA and SCID Revenue Market Share by Player (2019-2024)
Table 13. Newborn Screening for SMA and SCID Key Players Head office and Products Offered
Table 14. Newborn Screening for SMA and SCID Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Newborn Screening for SMA and SCID Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Newborn Screening for SMA and SCID Market Size Market Share by Regions (2019-2024)
Table 19. Global Newborn Screening for SMA and SCID Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Newborn Screening for SMA and SCID Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Newborn Screening for SMA and SCID Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Newborn Screening for SMA and SCID Market Size Market Share by Country (2019-2024)
Table 23. Americas Newborn Screening for SMA and SCID Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Table 25. Americas Newborn Screening for SMA and SCID Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Table 27. APAC Newborn Screening for SMA and SCID Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Newborn Screening for SMA and SCID Market Size Market Share by Region (2019-2024)
Table 29. APAC Newborn Screening for SMA and SCID Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Table 31. APAC Newborn Screening for SMA and SCID Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Table 33. Europe Newborn Screening for SMA and SCID Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Newborn Screening for SMA and SCID Market Size Market Share by Country (2019-2024)
Table 35. Europe Newborn Screening for SMA and SCID Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Table 37. Europe Newborn Screening for SMA and SCID Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Newborn Screening for SMA and SCID
Table 46. Key Market Challenges & Risks of Newborn Screening for SMA and SCID
Table 47. Key Industry Trends of Newborn Screening for SMA and SCID
Table 48. Global Newborn Screening for SMA and SCID Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Newborn Screening for SMA and SCID Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Newborn Screening for SMA and SCID Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Newborn Screening for SMA and SCID Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Perkinelmer Details, Company Type, Newborn Screening for SMA and SCID Area Served and Its Competitors
Table 53. Perkinelmer Newborn Screening for SMA and SCID Product Offered
Table 54. Perkinelmer Newborn Screening for SMA and SCID Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Perkinelmer Main Business
Table 56. Perkinelmer Latest Developments
Table 57. Thermo Fisher Details, Company Type, Newborn Screening for SMA and SCID Area Served and Its Competitors
Table 58. Thermo Fisher Newborn Screening for SMA and SCID Product Offered
Table 59. Thermo Fisher Main Business
Table 60. Thermo Fisher Newborn Screening for SMA and SCID Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Thermo Fisher Latest Developments
Table 62. ImmunoIVD Details, Company Type, Newborn Screening for SMA and SCID Area Served and Its Competitors
Table 63. ImmunoIVD Newborn Screening for SMA and SCID Product Offered
Table 64. ImmunoIVD Main Business
Table 65. ImmunoIVD Newborn Screening for SMA and SCID Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. ImmunoIVD Latest Developments
Table 67. Labsystems Diagnostics Details, Company Type, Newborn Screening for SMA and SCID Area Served and Its Competitors
Table 68. Labsystems Diagnostics Newborn Screening for SMA and SCID Product Offered
Table 69. Labsystems Diagnostics Main Business
Table 70. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Labsystems Diagnostics Latest Developments
LIST OF FIGURES
Figure 1. Newborn Screening for SMA and SCID Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Newborn Screening for SMA and SCID Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Newborn Screening for SMA and SCID Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Newborn Screening for SMA and SCID Sales Market Share by Country/Region (2023)
Figure 8. Newborn Screening for SMA and SCID Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Newborn Screening for SMA and SCID Market Size Market Share by Type in 2023
Figure 10. Newborn Screening for SMA and SCID in SCID Screening
Figure 11. Global Newborn Screening for SMA and SCID Market: SCID Screening (2019-2024) & ($ Millions)
Figure 12. Newborn Screening for SMA and SCID in SMA Screening
Figure 13. Global Newborn Screening for SMA and SCID Market: SMA Screening (2019-2024) & ($ Millions)
Figure 14. Global Newborn Screening for SMA and SCID Market Size Market Share by Application in 2023
Figure 15. Global Newborn Screening for SMA and SCID Revenue Market Share by Player in 2023
Figure 16. Global Newborn Screening for SMA and SCID Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Newborn Screening for SMA and SCID Market Size 2019-2024 ($ Millions)
Figure 18. APAC Newborn Screening for SMA and SCID Market Size 2019-2024 ($ Millions)
Figure 19. Europe Newborn Screening for SMA and SCID Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Newborn Screening for SMA and SCID Market Size 2019-2024 ($ Millions)
Figure 21. Americas Newborn Screening for SMA and SCID Value Market Share by Country in 2023
Figure 22. United States Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Newborn Screening for SMA and SCID Market Size Market Share by Region in 2023
Figure 27. APAC Newborn Screening for SMA and SCID Market Size Market Share by Type in 2023
Figure 28. APAC Newborn Screening for SMA and SCID Market Size Market Share by Application in 2023
Figure 29. China Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Newborn Screening for SMA and SCID Market Size Market Share by Country in 2023
Figure 36. Europe Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Figure 37. Europe Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Figure 38. Germany Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 52. APAC Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 53. Europe Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 55. United States Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 56. Canada Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 59. China Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 60. Japan Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 61. Korea Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 63. India Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 64. Australia Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 65. Germany Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 66. France Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 67. UK Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 68. Italy Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 69. Russia Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 70. Spain Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 73. Israel Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 76. Global Newborn Screening for SMA and SCID Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Newborn Screening for SMA and SCID Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Newborn Screening for SMA and SCID Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Newborn Screening for SMA and SCID Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Newborn Screening for SMA and SCID Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Newborn Screening for SMA and SCID Sales Market Share by Country/Region (2023)
Figure 8. Newborn Screening for SMA and SCID Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Newborn Screening for SMA and SCID Market Size Market Share by Type in 2023
Figure 10. Newborn Screening for SMA and SCID in SCID Screening
Figure 11. Global Newborn Screening for SMA and SCID Market: SCID Screening (2019-2024) & ($ Millions)
Figure 12. Newborn Screening for SMA and SCID in SMA Screening
Figure 13. Global Newborn Screening for SMA and SCID Market: SMA Screening (2019-2024) & ($ Millions)
Figure 14. Global Newborn Screening for SMA and SCID Market Size Market Share by Application in 2023
Figure 15. Global Newborn Screening for SMA and SCID Revenue Market Share by Player in 2023
Figure 16. Global Newborn Screening for SMA and SCID Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Newborn Screening for SMA and SCID Market Size 2019-2024 ($ Millions)
Figure 18. APAC Newborn Screening for SMA and SCID Market Size 2019-2024 ($ Millions)
Figure 19. Europe Newborn Screening for SMA and SCID Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Newborn Screening for SMA and SCID Market Size 2019-2024 ($ Millions)
Figure 21. Americas Newborn Screening for SMA and SCID Value Market Share by Country in 2023
Figure 22. United States Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Newborn Screening for SMA and SCID Market Size Market Share by Region in 2023
Figure 27. APAC Newborn Screening for SMA and SCID Market Size Market Share by Type in 2023
Figure 28. APAC Newborn Screening for SMA and SCID Market Size Market Share by Application in 2023
Figure 29. China Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Newborn Screening for SMA and SCID Market Size Market Share by Country in 2023
Figure 36. Europe Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Figure 37. Europe Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Figure 38. Germany Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Newborn Screening for SMA and SCID Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Newborn Screening for SMA and SCID Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 52. APAC Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 53. Europe Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 55. United States Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 56. Canada Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 59. China Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 60. Japan Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 61. Korea Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 63. India Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 64. Australia Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 65. Germany Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 66. France Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 67. UK Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 68. Italy Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 69. Russia Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 70. Spain Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 73. Israel Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Newborn Screening for SMA and SCID Market Size 2025-2030 ($ Millions)
Figure 76. Global Newborn Screening for SMA and SCID Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Newborn Screening for SMA and SCID Market Size Market Share Forecast by Application (2025-2030)
